Progress in Cardiovascular Diseases

Papers
(The median citation count of Progress in Cardiovascular Diseases is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
List of recent issues181
From the editor's desk-overweight and obesity and obesity paradox in cardiovascular diseases140
Cover 2 (Masthead)132
Table of contents69
CTA in roadmapping post-CABG evaluation68
Shelter from the cytokine storm: Healthy living is a vital preventative strategy in the COVID-19 era57
Chronic thrombosis of bioprostheses: Diagnosis and management47
Clinical characteristics and mortality after acute myocardial infarction-related hospitalization among Asians from a national population-based cohort study46
Cover 2 (Masthead)45
List of recent issues45
Table of contents44
Cover 2 (Masthead)41
Cover 2 (Masthead)40
Use of mechanical circulatory support in high-risk percutaneous coronary interventions39
Multimodality imaging of hypertrophic cardiomyopathy35
Table of contents35
Revisiting high-density lipoprotein cholesterol in cardiovascular disease: Is too much of a good thing always a good thing?34
Updates on obesity and the obesity paradox in cardiovascular diseases33
Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosis33
Cover 2 (Masthead)33
Association of polypill therapy with cardiovascular outcomes, mortality, and adherence: A systematic review and meta-analysis of randomized controlled trials33
Evidence to support health system prioritization of health behaviors in the COVID-19 era33
Estrogen and cardiovascular disease33
Using cardiorespiratory fitness assessment to identify pathophysiology in long COVID – Best practice approaches32
List of recent issues31
Editorial Board29
The weekly mortality for ischemic heart disease in the US still peaks on mondays28
Assessment of lifestyle-related risk factors enhances the effectiveness of cardiac stress testing28
Patient reported outcomes in obstructive hypertrophic cardiomyopathy undergoing myectomy: Results from SPIRIT-HCM study28
A meta-analysis of direct oral anticoagulants vs warfarin for left ventricular thrombus28
Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know27
Association between hypercholesterolemia and mortality risk among patients referred for cardiac imaging test: Evidence of a “cholesterol paradox?”26
Refining cardiovascular risk assessment: The interplay of lipoprotein (a) and waist-to-hip ratio24
List of recent issues24
Anti-consumption agents: Tirzepatide and semaglutide for treating obesity-related diseases and addictions, and improving life expectancy24
Supervised exercise therapy for patients with peripheral artery disease: Clinical update and pathways forward24
Normative values for body composition in 22,191 healthy Norwegian adults 20–99 years: The HUNT4 study23
Outcomes of untreated subclinical antibody-mediated rejection after heart transplantation23
Cardiac rehabilitation 202223
Incidence of acute myocardial infarction and hurricane Katrina: Fourteen years after the storm22
Editorial Board22
Impact of age on the utility of CardioMEMS device in reducing heart failure readmissions22
Testosterone therapy and the risk of cardiovascular disease in older, hypogonadal men22
Table of contents22
Benefits and drawbacks of statins and non-statin lipid lowering agents in carotid artery disease21
Omega-3 and Risk of atrial fibrillation: Vagally-mediated double-edged sword21
The polypill strategy in cardiovascular disease prevention: It's time for its implementation21
Antegrade techniques for chronic total occlusion percutaneous coronary intervention20
Editorial Board20
The connection between sleep deficiency and coronary artery disease: Complexities and controversies20
Table of contents20
Developing effective strategies to optimize physical activity and cardiorespiratory fitness in the long Covid population- The need for caution and objective assessment19
Reflections on community experience with Mavacamten19
No second chances: Cardiovascular death is the most frequent incident event among patients with coronary artery calcium19
Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Exam18
Leisure time versus occupational physical activity for cardiometabolic risk18
Of meat & molecules18
Are statins beneficial in patients with vasospastic angina? A meta-analysis of observational studies18
Social justice equity in healthy living medicine - An international perspective18
Multimodality imaging for prosthetic valves evaluation: Current understanding and future directions18
Unmet needs and future directions in hypertrophic cardiomyopathy18
Different right ventricular dysfunction and pulmonary coupling in acute heart failure according to the left ventricular ejection fraction17
Dose-response associations of the American Heart Association's new “Life's essential 8” metrics with all-cause and cardiovascular mortality in a nationally representative sample from the United States17
Prosthesis-patient mismatch following aortic and mitral valves replacement – A comprehensive review17
Exercise and cardiovascular health: A state-of-the-art review17
Table of contents17
Debunking the vegan myth: The case for a plant-forward omnivorous whole-foods diet17
HCM's hidden cost: The impact of socioeconomic status17
Prognostic value of troponin I in atrial fibrillation17
Dose-response association of an accelerometer-measured physical activity with all-cause mortality and cardiovascular disease incidence: Prospective cohort with 76,074 participants17
The culture of healthy living – Exploring the chaos that drives health behaviors17
Effect of inclisiran on lipid and mechanical vascular profiles in familial hypercholesterolemia subjects: results from a single lipid center real-world experience17
Adipo-cardiology: The next frontier in cardiovascular disease16
Predicting life expectancy in the United States: The importance of healthy living behaviors and residential geography16
Self-reported walking pace and 10-year cause-specific mortality: A UK biobank investigation16
Recognizing risk factors associated with poor outcomes among patients with COVID-1916
Comparison of risk profiles of participants in the Women's IschemiA TRial to Reduce events In non-ObstRuctive CAD (WARRIOR) trial, using Coronary Computed Tomography Angiography vs Invasive Coronary A16
Editorial Board15
A successful home-based cardiac rehabilitation program in the early phase of the COVID-19 pandemic15
Trends in pneumococcal vaccination in patients presenting with acute coronary syndrome in the United States15
The physiologic benefits of optimizing cardiorespiratory fitness and physical activity – From the cell to systems level in a post-pandemic world15
Cover 2 (Masthead)15
Popular fad diets: An evidence-based perspective14
Systems science approaches to cardiovascular disease prevention and management in the era of COVID-19: A Humpty-Dumpty dilemma?14
Incremental benefits of combined inhibition of SGLT1 and SGLT2 with sotagliflozin14
Optical coherence tomography angiography in cardiovascular disease14
Temporary mechanical circulatory support in cardiogenic shock14
Nine Years as Editor-in Chief of Progress in Cardiovascular Diseases13
The obesity wars and the education of a researcher: A personal account13
Prognostic value of age-sex adjusted NT-proBNP ratio in obstructive hypertrophic cardiomyopathy13
Health equity in heart failure13
Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)13
Effect of BMI on patients undergoing transcatheter aortic valve implantation: A systematic review and meta-analysis13
Can the outlier percentiles from norms increase the sensitivity of the ECG criteria for screening athletes?13
Social determinants of health, health disparities, and adiposity12
Cardiorespiratory fitness and physical activity in the lens of social justice – Reporting on the disparities that exist12
Tricuspid valve replacement: The old and the new12
Differential effects of overweight/obesity depending on the severity of heart failure complicating acute myocardial infarction in Japan12
Association of neighborhood median income to outcomes in hypertrophic cardiomyopathy12
Statin associated muscle symptoms: An update and review12
Prioritizing the primary prevention of heart failure: Measuring, modifying and monitoring risk12
COVID-19, Unhealthy lifestyle behaviors and chronic disease in the United States: Mapping the social injustice overlay12
Subclinical atherosclerosis on chest computed tomography and mortality in young patients with severe hypercholesterolemia12
Exercise blood pressure, cardiorespiratory fitness and mortality risk12
Assessing race and ethnicity differences in outcomes based on GDMT and target NT-proBNP in patients with heart failure with reduced ejection fraction: An analysis of the GUIDE-IT study11
Progress in Cardiovascular Diseases Statistics 202211
Dietary dilemmas11
Pulsed field ablation: The basics relating to effectiveness, durability, and safety11
Editorial Board11
Building a culture of healthy living in the workplace11
Enhancing participation in cardiac rehabilitation: Focus on underserved populations11
List of recent issues11
Mitral valve diseases: Pathophysiology and interventions11
Catheter based interventions for lower extremity peripheral artery disease10
Editor handoff PCVD10
Recommendations on the use of artificial intelligence in health promotion10
Cardiovascular disease prevention and management in the COVID-19 era and beyond: An international perspective10
The importance of healthy lifestyle behaviors in the prevention of cardiovascular disease10
Clinical conundrums involving statin drug-drug interactions10
Peak oxygen pulse and mortality risk in healthy women and men: The Ball State Adult Fitness Longitudinal Lifestyle Study (BALL ST)10
Social justice as it relates to healthy living behaviors and medicine: The current state of inequity and the path forward10
A review of the interplay between Takotsubo cardiomyopathy and adrenal insufficiency: Catecholamine surge and glucocorticoid deficiency9
A culture of health promotion in healthcare: Can't pour from an empty cup9
Cover 2 (Masthead)9
Complications of percutaneous coronary intervention9
Racial and ethnic disparities in cardiometabolic disease and COVID-19 outcomes in White, Black/African American, and Latinx populations: Physiological underpinnings9
Insight into different phenotypic presentations of heart failure with preserved ejection fraction9
Role of multimodality imaging in infective endocarditis: Contemporary diagnostic and prognostic considerations9
Exercise as a therapeutic modality for the prevention and treatment of depression9
Table of contents9
Editorial Board9
Editorial Board8
Impressive results with EPA, but EPA/DHA combinations also reduce cardiovascular outcomes8
Why are COVID-19 effects less severe in Sub-Saharan Africa? Moving more and sitting less may be a primary reason8
Pathophysiology, diagnosis and management of right ventricular failure: A state of the art review of mechanical support devices8
Advances in the management of heart failure8
The culture of healthy living in communities8
Assessing cardiorespiratory fitness in clinical and community settings: Lessons and advancements in the 100th year anniversary of VO2max8
Innovation in intervention8
Complex high-risk indicated percutaneous coronary intervention (CHIP): Introduction8
Initiation of anti-hypertensive drugs and outcomes in patients with heart failure with preserved ejection fraction and persistent hypertension8
Cardiovascular disease in space: A systematic review7
Invasive therapies for symptomatic obstructive hypertrophic cardiomyopathy7
The inclusion and consideration of cultural differences and health inequalities in physical activity behaviour in the UK - the impact of guidelines and initiatives7
Current state of unhealthy living characteristics in White, African American and Latinx populations7
Stepping up physical activity and fitness is needed for longevity7
Cardiopulmonary exercise testing during the COVID-19 pandemic7
The role of mechanical valves in the aortic position in the era of bioprostheses and TAVR: Evidence-based appraisal and focus on the On-X valve7
Prevalence of cardiovascular diseases in COVID-19 related mortality in the United States7
Table of contents7
New models for heart failure care delivery7
Individual sentiments on telehealth in the COVID-19 era: Insights from Twitter7
Non-atherosclerotic coronary causes of myocardial infarction in women7
Exercise heart rate reserve and recovery as risk factors for sudden cardiac death7
Prevalence of familial hypercholesterolemia in a country-wide laboratory network in Pakistan: 10-year data from 988, 306 patients7
Editorial Board7
Maturity-onset diabetes of the young (MODY) - in search of ideal diagnostic criteria and precise treatment7
Review of recent clinical trials and their impact on the treatment of hypercholesterolemia7
Artificial intelligence in preventive cardiology6
Healthy and unhealthy plant-based diets and the risk of cardiovascular diseases: The Rotterdam study and updated meta-analysis6
Cultural influences on dietary choices6
Table of contents6
Update on chronic total occlusion percutaneous coronary intervention6
Hypertrabeculation; a phenotype with Heterogeneous etiology6
Public policy for healthy living: How COVID-19 has changed the landscape6
Landscape of stroke comorbidities: A disease-wide association study6
Cardioneuroablation: Three different approaches6
Substances use and risk of hypertension before midlife in military young adults: CHIEF cohort study, 2014–20206
Antithrombotic treatment for valve prostheses: Which drug, which dose, and when?6
Potential implications of the FDA approval of semaglutide for overweight and obese adults in the United States6
Update on obesity, the obesity paradox, and obesity management in heart failure6
The invisible value of physical activity6
Fairness in scientific debate6
The current state of evidence for sodium and fluid restriction in heart failure6
Assessing the potential of ChatGPT for patient education in the cardiology clinic5
Bridging the adherence gap in ASCVD: Aligning patient and provider perspectives on lipid-lowering therapy5
Current state of unhealthy living characteristics in Black/African American and Latino populations: Tobacco use5
Cover 2 (Masthead)5
A perpetual state of bad dreams: The prevention and management of cardiovascular disease in the COVID-19 pandemic era and beyond5
A social ecological perspective on interventions to address short sleep duration in adults with coronary heart disease5
The current state of physical activity assessment and interventions with public policy solutions5
Understanding the spectrum of cardiovascular risk in women - A primer for prevention5
Cover 2 (Masthead)5
Retrograde approach to chronic total occlusion percutaneous coronary interventions- Technique and outcomes5
Cardiovascular statistics 20235
Coronary artery disease and percutaneous coronary intervention in patients with severe chronic kidney disease5
The utility of coronary artery calcium scoring to enhance cardiovascular risk assessment for South Asian adults5
Implantable devices for heart failure monitoring5
Special Assorted Topics 20215
Long-term continuous exercise training counteracts the negative impact of the menopause transition on cardiometabolic health in hypertensive women - a 9-year RCT follow-up5
Where are we now? The intersection of healthy living medicine and social justice within our school systems4
Cover 2 (Masthead)4
List of recent issues4
Table of contents4
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)4
Prioritizing movement to address the frailty phenotype in heart failure4
Current gaps in HFpEF trials: Time to reconsider patients' selection and to target phenotypes4
Unlocking insights: Clinical associations from the largest 6-minute walk test collection via the my Heart Counts Cardiovascular Health Study, a fully digital smartphone platform4
Contemporary technologies to modify calcified plaque in coronary artery disease4
List of recent issues4
Chronic psychological stress and cardiovascular disease risk: When to use single biomarkers versus allostatic load4
Advances in the diagnosis and treatment of transthyretin amyloid cardiomyopathy4
List of recent issues4
Stemming the chronic disease pandemic through a generational shift in public health policy and practice4
The common pathobiology between coronary artery disease and calcific aortic stenosis: Evidence and clinical implications4
Obesity and atrial fibrillation: Prevalence, pathogenesis, and prognosis4
Cover 2 (Masthead)4
Omega-3 fatty acids in primary and secondary prevention of cardiovascular diseases4
Myocarditis associated with COVID-19 and its vaccines - a systematic review4
Psychological distress in cardiovascular diseases and impact of cardiac rehabilitation programs4
The evolving paradigm and current perception of hypertrophic cardiomyopathy: Implications for management3
The fitness fortress - all are welcome, but far too few choose to enter and stay3
Coronary microvascular dysfunction beyond the spectrum of chronic coronary syndromes3
Table of contents3
Continuing a legacy of excellence: A new chapter for Progress in Cardiovascular Diseases3
List of recent issues3
Leisure-time physical activity is more strongly associated with cardiometabolic risk than occupational physical activity: Results from a workplace lifestyle modification program3
The American Nations model: An analytical tool for understanding the influence of U.S. regional cultures on health and the social and political determinants of health3
Heart failure with improved ejection fraction: Beyond diagnosis to trajectory analysis3
Exercising immune cells: The immunomodulatory role of exercise on atrial fibrillation3
Editorial Board3
Association of participation in Cardiac Rehabilitation with Social Vulnerability Index: The behavioral risk factor surveillance system3
Evolution of genetic testing and gene therapy in hypertrophic cardiomyopathy3
The response to the COVID-19 pandemic: With hindsight what lessons can we learn?3
Medical therapies for hypertrophic cardiomyopathy: Current state of the art3
Evidence does not support benefit of being overweight on mortality3
Assorted topics III 20243
The associations between exercise and lipid biomarkers3
Racial and ethnic disparities in cardiometabolic disease and COVID-19 outcomes in White, Black/African American, and Latinx populations: Social determinants of health3
Left atrial appendage closure – Current status and future directions3
Heart Failure and Obesity: The Latest Pandemic3
Proposed enhanced recommendations for interpretation of electrocardiographic screening of athletes3
Income disparity and incident cardiovascular disease in older Americans2
Table of contents2
To the editor: Artificial intelligence applied to ECG predicts mortality after a transcatheter aortic valve replacement2
Cardiorespiratory fitness as a vital sign of CVD risk in the COVID-19 era2
Unveiling the burden of acute myocardial infarction deaths associated with COVID-19 during the first five years of the pandemic2
List of recent issues2
Over a decade as editor-in-chief at Progress in Cardiovascular Diseases2
Pulmonary comorbidities in cardiac rehabilitation2
Calcified plaque modification during percutaneous coronary revascularization2
Artificial intelligence in cardiac computed tomography2
List of recent issues2
Resistance exercise for cardiac rehabilitation2
Associations of total and aerobic steps with the prevalence and incidence of frailty in older adults with hypertension2
List of recent issues2
Inequities in atherosclerotic cardiovascular disease prevention2
Transcatheter mitral valve interventions2
Assessment of lifestyle “vital signs” in healthcare settings2
MitraClip for secondary mitral regurgitation: Patient selection2
0.073247909545898